Duffy antigen system
Duffy antigen/chemokine receptor (DARC), also known as Fy glycoprotein (FY) or CD234 (Cluster of Differentiation 234), is a protein that in humans is encoded by the ACKR1 gene.
≈ 7 min read
Duffy antigen system. encyclopegia.org, snapshot enwiki-001377962476. /a/duffy-antigen-system
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Duffy antigen/chemokine receptor (DARC), also known as Fy glycoprotein (FY) or CD234 (Cluster of Differentiation 234), is a protein that in humans is encoded by the ACKR1 gene. The Duffy antigen is located on the surface of red blood cells, and is named after the patient in whom it was discovered.
The protein encoded by this gene is a glycosylated membrane protein and a non-specific receptor for several chemokines. The protein is also the receptor for the human malarial parasites Plasmodium vivax, Plasmodium knowlesi and simian malarial parasite Plasmodium cynomolgi. Polymorphisms in this gene are the basis of the Duffy blood group system.
Differences in the racial distribution of the Duffy antigens were discovered in 1954, when it was found that the overwhelming majority of people of African descent had the erythrocyte phenotype Fy(a-b-): 68% in African Americans and 88-100% in African people (including more than 90% of West African people). This phenotype is exceedingly rare in Whites.
Because the Duffy antigen is uncommon in those of Black African descent, the presence of this antigen has been used to detect genetic admixture. In a sample of unrelated African Americans (n = 235), Afro-Caribbeans (n = 90) and Colombians (n = 93), the frequency of the -46T (Duffy positive) allele was 21.7%, 12.2% and 74.7% respectively.
Overall the frequencies of Fya and Fyb antigens in Whites are 66% and 83% respectively, in Asians 99% and 18.5% respectively and in blacks 10% and 23% respectively. The frequency of Fy3 is 100% Whites, 99.9% Asians and 32% Blacks.
Phenotype frequencies are: Fy(a+b+): 49% Whites, 1% Blacks, 9% Chinese Fy(a-b+): 34% Whites, 22% Blacks, A in the first codon position—base number 298) within the FY*B allele was thought to be purely a White genotype, but has since been described in Brazilians. However, the study's authors point out that the Brazilian population has arisen from intermarriage between Portuguese, Black Africans, and Indians, which accounts for the presence of this mutation in a few members of Brazil's non-White groups.
Two of the three Afro-Brazilian test subjects that were found to have the mutation (out of a total of 25 Afro-Brazilians tested) were also related to one another, as one was a mother and the other her daughter. This antigen along with other blood group antigens was used to identify the Basque people as a genetically separate group. Its use in forensic science is under consideration.
The Andaman and Nicobar Islands, part of India, were originally inhabited by 14 aboriginal tribes. Several of these have gone extinct. One surviving tribe—the Jarawas—live in three jungle areas of South Andaman and one jungle area in Middle Andaman.
The area is endemic for malaria. The causative species is Plasmodium falciparum: there is no evidence for the presence of Plasmodium vivax. Blood grouping revealed an absence of both Fy(a) and Fy(b) antigens in two areas and a low prevalence in two others.
Among Yemenite Jews the frequency of the Fy allele is 0.5879. The frequency of this allele varies from 0.1083 to 0.2191 among Jews from the Middle East, North Africa and Southern Europe. The incidence of Fya among Ashkenazi Jews is 0.44 and among the non-Ashkenazi Jews it is 0.33.
The incidence of Fyb is higher in both groups with frequencies of 0.53 and 0.64 respectively. In Chinese ethnic populations—the Han and the She people—the frequencies of Fya and Fyb alleles were 0.94 and 0.06 and 0.98 and 0.02 respectively. The frequency of the Fya allele in most Asian populations is ~95%.
In Grande Comore (also known as Ngazidja) the frequency of the Fy(a- b-) phenotype is 0.86. The incidence of Fy(a+b-) in northern India among blood donors is 43.85%. In the Maghreb, Horn of Africa and the Nile Valley, the Afroasiatic (Hamitic-Semitic) speaking populations are largely Duffy-positive.
Between 70%-98% of Hamito-Semitic groups in Ethiopia were found to be Duffy-positive. Serological and DNA based analysis of 115 unrelated Tunisians also found an FY*X frequency of 0.0174; FY*1 = 0.291 (expressed 0.260, silent 0.031); FY*2 = 0.709 (expressed 0.427; silent 0.282).
Since the FY*2 silent is the most common allele in West Africa, its minor occurrence in the sample probably represents recent diffusion from the latter region. In Nouakchott, Mauritania overall 27% of the population are Duffy-positive. 54% of Moors are Duffy antigen positive, while only 2% of black ethnic groups (mainly Poular, Soninke and Wolof) are Duffy positive.
A map of the Duffy antigen distribution has been produced. The most prevalent allele globally is FY*A. Across sub-Saharan Africa the predominant allele is the silent FY*B ES variant. In Iran the Fy (a-b-) phenotype was found in 3.4%.
There appears to have been a selective sweep in Africa which reduced the incidence of this antigen there. This sweep appears to have occurred between 6,500 and 97,200 years ago (95% confidence interval) The distribution within India has been studied in some detail.
Inflammation
An association with the levels monocyte chemoattractant protein-1 has been reported. In the Sardinian population, an association of several variants in the DARC gene (coding and non-coding) correlates with increased serum levels of monocyte chemoattractant protein (MCP -1).
A new variant in this population, consisting of the amino acid substitution of arginine for a cysteine at position 89 of the protein diminishes the ability to bind chemokines. DARC has also been linked to rheumatoid arthritis (RA), possibly displaying chemokines such as CXCL5 on the surface of endothelial cells within the synovium, increasing the recruitment of neutrophils in the disease state.
Clinical diagnostic
Clinical testing in patient care for Duffy antigens follows published minimum quality and operational requirements, similar to red cell genotyping for any of the other recognized blood group systems. Molecular analysis can identify gene variants (alleles) that may affect Duffy antigens expression on the red cell membrane.
Transfusion data
International Society for Blood Transfusion (ISBT) symbol: FY ISBT number: 008 Gene symbol: FY Gene name: Duffy blood group Number of Duffy antigens: 6
Antibody type
Almost entirely IgG. IgG1 usually predominates. IgM does occur but is rare.
Antibody behavior
Anti-Fy a is a common antibody while anti-Fy b is approximately 20 times less common., They are reactive at body temperature and are therefore clinically significant, although they do not typically bind complement. Antibodies are acquired through exposure (pregnancy or history of blood transfusion) and subsequent alloimmunization. They display dosage (react more strongly to homozygous cells versus heterozygous cells).
Transfusion reactions
Typically mild but may be serious, even fatal. Although these usually occur immediately they may occur after a delay (up to 24 hours). These reactions are usually caused by anti-Fy a or anti-Fy b . anti-Fy3 may cause acute or delayed hemolytic transfusion reactions, but only rarely. Anti-Fy5 may also cause delayed hemolytic transfusion reactions.
Hemolytic disease of the fetus and newborn
Hemolytic disease of the fetus and newborn is typically mild but rarely may be serious. Almost always due to anti-Fy a and rarely anti-Fyb or Fy3. Duffy at BGMUT Blood Group Antigen Gene Mutation Database at NCBI, NIH Duffy gene Population data
Text derived from https://en.wikipedia.org/w/index.php?oldid=1377962476 under CC BY-SA 4.0; modifications have been made.